Asymmetric amyloid deposition in preclinical Alzheimer's disease: A PET study.

Amyloid deposition Asymmetry Positron emission tomography Preclinical Alzheimer’s disease

Journal

Aging brain
ISSN: 2589-9589
Titre abrégé: Aging Brain
Pays: Netherlands
ID NLM: 101776137

Informations de publication

Date de publication:
2022
Historique:
received: 13 04 2022
revised: 05 08 2022
accepted: 06 08 2022
entrez: 13 3 2023
pubmed: 14 3 2023
medline: 14 3 2023
Statut: epublish

Résumé

The typical spatial pattern of amyloid-β (Aβ) in diagnosed Alzheimer's disease (AD) is that of a symmetrical hemispheric distribution. However, Aβ may be asymmetrically distributed in early stages of AD. Aβ distribution on PET has previously been explored in MCI and AD, but it has yet to be directly investigated in preclinical AD (pAD). We examined how Aβ was distributed in individuals with pAD and MCI using In this PET study, 79 subjects were retrospectively enrolled, including 34 controls, 24 pAD, and 21 MCI. All subjects underwent The Aβ asymmetry index (AI) differed between groups, with pAD having the highest Aβ AI as compared to both controls and MCI. There was no clear Aβ lateralisation in pAD, but there was a non-significant trend towards Aβ being more left-lateralised in MCI. There were no correlations between the cognitive scores and Aβ AI or Aβ lateralisation in pAD or MCI. The distribution of Aβ is most asymmetrical in pAD, as Aβ first starts accumulating, and it then becomes less asymmetrical in MCI, when Aβ has spread further, suggesting that more pronounced asymmetrical Aβ distribution may be a distinguishing factor in pAD. Longitudinal studies examining the distribution of Aβ across the AD continuum are needed.

Identifiants

pubmed: 36908895
doi: 10.1016/j.nbas.2022.100048
pii: S2589-9589(22)00020-2
pmc: PMC9997142
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100048

Informations de copyright

© 2022 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

J Nucl Med. 2020 Dec;61(12):1825-1831
pubmed: 32414948
Sci Transl Med. 2014 Mar 19;6(228):228fs13
pubmed: 24648338
Sci Rep. 2020 Apr 29;10(1):7256
pubmed: 32350336
Nat Commun. 2017 Oct 31;8(1):1214
pubmed: 29089479
J Alzheimers Dis. 2006;9(3 Suppl):361-6
pubmed: 16914873
J Alzheimers Dis. 2011;25(2):347-57
pubmed: 21422522
Lancet Neurol. 2015 Apr;14(4):388-405
pubmed: 25792098
Psychiatry Res. 2002 Feb 15;114(1):39-50
pubmed: 11864808
Neurology. 2017 Nov 14;89(20):2031-2038
pubmed: 29046362
J Neuroinflammation. 2020 May 6;17(1):151
pubmed: 32375809
Lancet Neurol. 2010 Jan;9(1):119-28
pubmed: 20083042
Biochem Soc Trans. 2012 Aug;40(4):711-5
pubmed: 22817721
Brain. 2015 Oct;138(Pt 10):3089-99
pubmed: 26280595
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Hum Brain Mapp. 2003 Aug;19(4):224-47
pubmed: 12874777
Neuropsychologia. 2011 Jul;49(9):2776-83
pubmed: 21689670
Neurobiol Aging. 2019 Jul;79:50-58
pubmed: 31026622
Brain. 2017 Jul 1;140(7):2002-2011
pubmed: 28575151
Br J Psychiatry. 1982 Jun;140:566-72
pubmed: 7104545
J Neuroimaging. 2019 Jul;29(4):499-505
pubmed: 31074062
Clin Nucl Med. 2021 Jul 1;46(7):527-531
pubmed: 33883492
Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9649-53
pubmed: 8415756
Neurobiol Aging. 1997 Jul-Aug;18(4):351-7
pubmed: 9330961
Neurology. 2002 Jun 25;58(12):1791-800
pubmed: 12084879
Alzheimers Dement. 2011 May;7(3):280-92
pubmed: 21514248
J Parkinsons Dis. 2021;11(4):1677-1687
pubmed: 34334424
Ann Neurol. 2004 Mar;55(3):306-19
pubmed: 14991808

Auteurs

Pernille L Kjeldsen (PL)

Dept. of Clinical Medicine, Aarhus University, Denmark.
Dept. of Nuclear Medicine and PET, Aarhus University Hospital, Denmark.

Peter Parbo (P)

Dept. of Clinical Medicine, Aarhus University, Denmark.
Dept. of Nuclear Medicine, Odense University Hospital, Denmark.

Kim V Hansen (KV)

Dept. of Nuclear Medicine and PET, Aarhus University Hospital, Denmark.

Joel F A Aanerud (JFA)

Dept. of Nuclear Medicine and PET, Aarhus University Hospital, Denmark.

Rola Ismail (R)

Dept. of Nuclear Medicine, Vejle, Lillebælt Hospital, Denmark.

Peter H Nissen (PH)

Dept. of Clinical Medicine, Aarhus University, Denmark.
Dept. of Clinical Biochemistry, Aarhus University Hospital, Denmark.

Rikke B Dalby (RB)

Dept. of Clinical Medicine, Aarhus University, Denmark.
Dept. of Radiology, Section for Neuroradiology, Aarhus University Hospital, Denmark.
Centre for Functionally Integrative Neuroscience, Aarhus University, Denmark.

Malene F Damholdt (MF)

Dept. of Clinical Medicine, Aarhus University, Denmark.
Dept. of Psychology, Aarhus University, Denmark.

Per Borghammer (P)

Dept. of Clinical Medicine, Aarhus University, Denmark.
Dept. of Nuclear Medicine and PET, Aarhus University Hospital, Denmark.

David J Brooks (DJ)

Dept. of Clinical Medicine, Aarhus University, Denmark.
Dept. of Nuclear Medicine and PET, Aarhus University Hospital, Denmark.
Translational and Clinical Research Institute, Newcastle University, United Kingdom.

Classifications MeSH